Heparin-induced thrombocytopenia (HIT) is a serious drug reaction that leads to a decrease in platelet count and a high risk of thrombosis. HIT patients produce pathogenic immunoglobulin G (IgG) antibodies that bind to complexes of platelet factor-4 (PF4) and heparin. HIT immune complexes crosslink Fc-receptors resulting in platelet and monocyte activation. These events lead to the release of procoagulant chemokines and tissue factor, which together create an intensely prothrombotic state. HIT represents an atypical immune response because it has features of both T cell-dependent and T cell-independent mechanisms. The disorder is characterized by newly formed anti-PF4/heparin IgG antibodies, which are characteristic of a T cell-dependent mechanism; however, re-exposure to heparin, months after HIT, does not lead to a memory response, which is consistent with a T cell-independent mechanism. In this review, we discuss the immunobiological events that can explain these features, including the role for T cell-dependent and T cellindependent mechanisms in HIT antibody generation, the immunogenic characteristics of the PF4/heparin antigen, and the concept of a temporary loss in immune regulation contributing to the onset of HIT. We also present a novel immunobiological model to explain the atypical immune response that is characteristic of HIT.
Heparin is a naturally occurring polysaccharide that is routinely administered to prevent and treat thrombosis (Chong, 2003) . Unfortunately, an estimated 5% of patients that are administered heparin develop heparin-induced thrombocytopenia (HIT) (Warkentin et al, 2005) . HIT is an immunemediated drug reaction that leads to a decrease in platelet count and a 30-fold increase in the risk of thrombosis (Girolami et al, 2003) . Immunoglobulin G (IgG) antibodies are produced against complexes of platelet factor-4 (PF4, also known as CXCL4) and heparin (Kelton et al, 1994) . PF4 is a small cationic chemokine that is released by platelets (Zucker & Katz, 1991) . It has a high affinity for negatively charged molecules, including heparin and cellular glycosaminoglycans (GAGs) (Rauova et al, 2006) . Due to this strong binding affinity, heparin infusion can lead to the formation of PF4/ heparin complexes .
PF4 bound to heparin exposes epitopes that become the target of anti-PF4/heparin antibodies (Brandt et al, 2014) ; however, only a subset of patients exposed to heparin produce IgG-specific anti-PF4/heparin antibodies and a smaller subset of patients produce pathogenic antibodies that can cause HIT (Nazi et al, 2015) . In HIT, pathogenic IgG antibodies bound to PF4/heparin crosslink Fc-receptors on platelets and monocytes to induce the release of procoagulant factors, which promote the onset of thrombosis (Hughes et al, 2000) . HIT often occurs in critically ill patients following major cardiac or orthopaedic surgery ; its onset is due to a convergence of clinical factors: the severity of tissue trauma (Lubenow et al, 2010) , the type of heparin administered (Warkentin & Eikelboom, 2007) , the duration of heparin therapy (Martel et al, 2005) , and the titre of HIT antibodies (Nazi et al, 2015) . Up to 70% of patients who undergo cardiopulmonary bypass (CPB) surgery produce anti-PF4/heparin antibodies (Warkentin et al, 2013 ), yet only 2-3% of these patients develop HIT . Nucleic acids, which increase in plasma as a result of surgery (Ren et al, 2013) , also form PF4/nucleic acid complexes that bind anti-PF4/heparin antibodies and elicit platelet activation independent of heparin (Jaax et al, 2013) . Moreover, HIT can occur in patients who have not been exposed to heparin, which suggests that other factors, such as tissue trauma alone, can elicit HIT antibody production . Polymorphisms of Fc-receptor genes can also impact antibody-mediated platelet activation and the likelihood of developing thrombosis in HIT (Rollin et al, 2013 . Taken together, these studies suggest that HIT depends on a complex interplay of clinical and genetic factors.
The antibody response characteristic of HIT has several unique features that do not fit any one classic antibody response (Potschke et al, 2012) . With most primary antibody responses, initial antibody production is typically characterized by immunoglobulin M (IgM) antibody production within 5-10 days of primary antigen exposure, followed by minimal IgG antibody production, and the generation of memory cells (Warrington et al, 2011) . Secondary antibody responses activate memory cells and induce the rapid production of high-affinity IgG antibodies after antigen re-exposure. HIT has features of both primary and secondary antibody responses, because high titres of anti-PF4/heparin IgG antibodies (alongside IgM and IgA) are produced soon after primary heparin exposure . HIT is, however, also classified as non-anamnestic, because repeat exposure to heparin does not lead to recurrent episodes of HIT (P€ otzsch et al, 2000) .
The immunogenesis of HIT remains poorly understood. In this review, we discuss the key role for T cells in HIT. We explain how a temporary loss of immune regulation can contribute to HIT immune activation. We also propose a model for HIT pathogenesis that reconciles the atypical immune features of this destructive drug reaction.
HIT has features of a T cell-dependent antibody response
In a T cell-dependent antibody response, antigen-presenting cells (APCs) display peptides to T-helper (T H ) cells, which go on to activate cognate follicular B cells (King, 2009) . APCs, including dendritic cells, macrophages and B cells, produce antigenic peptides that can be loaded onto major histocompatibility complex (MHC) class II. Primary exposure to immunogenic proteins leads to the expression of MHC class II-peptide complexes on APCs, which can be recognized by T cell receptors (TCR) on antigen-specific na€ ıve T cells. In conjunction with co-stimulatory signals, MHC class II-peptide interactions initiate T cell activation and differentiation into follicular T H cells. Typically, within 7 days of primary antigen exposure, follicular T H cells interact with cognate follicular B cells to induce germinal centre formation and differentiation into memory B cells and plasma cells that primarily produce IgM antibodies (De Silva & Klein, 2015) . With secondary antigen exposure, memory B cells rapidly differentiate into plasma cells that produce high-affinity IgG antibodies, which can remain in circulation for years (Cunningham et al, 2014) . The rapid and robust production of class-switched HIT antibodies following heparin exposure suggests that HIT is a secondary antibody response mediated by T cell-dependent mechanisms.
Antigen presentation in HIT
Tissue trauma may be critical in initiating the HIT antibody response. Surgical stress increases the expression of MHC class II on dendritic cells (Maier et al, 2009) ; furthermore, inflammation is associated with heightened platelet activation and PF4 release (Prechel & Walenga, 2013) . PF4 facilitates monocyte chemotaxis and monocyte differentiation into macrophages that do not express human leucocyte antigen (HLA)-DR (Kasper & Petersen, 2011) . Originally, HLA was shown not to be associated with HIT (Greinacher & MuellerEckhardt, 1993) ; however, HLA-DR, which is expressed in autoimmune disease, was more recently shown to be associated with both anti-PF4/heparin antibody production and HIT (Paparella et al, 2001; Karnes et al, 2015) . HLA-CW4, which is an HLA class I serotype expressed during inflammation, is also associated with anti-PF4/heparin antibody production after cardiac surgery (Paparella et al, 2008) . Exhaustive genomic screens of protein variants involved in antigen presentation can provide further insight into the early stages of the HIT antibody response. PF4 also induces monocyte differentiation into dendritic cells (Xia & Kao, 2003) , while co-stimulation of monocytes with PF4 and interleukin (IL)-4 generates functionally unique APCs (Fricke et al, 2004) . Moreover, heparin promotes monocyte differentiation into dendritic cells (Xia & Kao, 2002) and GAGs promote monocyte activation and B cell proliferation (Rachmilewitz & Tykocinski, 1998) . Thus, exposure to high concentrations of PF4 and heparin during surgery may potentiate the differentiation of cellular precursors into APCs that readily interact with antigen-specific T cells. Major surgery also induces widespread cellular damage (Dobson, 2015) and may supply the proinflammatory molecules that act as co-stimulatory signals for antigen presentation at the start of the HIT antibody response.
The intrinsic properties of PF4 are also important for its antigenicity and immunogenicity. PF4/heparin stoichiometry is critical for HIT antibody binding . Furthermore, PF4/heparin induces dendritic cells to secrete proinflammatory IL-12 (Chudasama et al, 2010) , while internalized PF4/heparin increases expression of both MHC class II and co-stimulatory markers on APCs (Joglekar et al, 2015) . Net cationic PF4/heparin complexes are more immunogenic than charge-neutralized PF4/heparin complexes (Suvarna et al, 2007) . Electrostatics and size can enhance the immunogenicity of particulate antigens (Thiele et al, 2001 ) and may influence the ability for PF4/heparin to interact with APCs and induce lymphocyte activation in HIT. Further research is required to elucidate how PF4/heparin stoichiometry affects the immunogenesis of HIT.
Class-switched antibodies in HIT
Antibody class switching from IgM to IgG is characteristic of a T cell-dependent response. In HIT, the initial antibody class is primarily IgG (along with IgM and/or IgA), and these antibodies appear a median of 4 days after primary heparin exposure (Greinacher et al, 2009; Warkentin et al, 2009 ). The rapid production of HIT IgG antibodies with primary heparin exposure may be due to class switching that occurred earlier in life in response to PF4 bound to polyanions expressed on bacteria (Krauel et al, 2011) and/or host cells (Rauova et al, 2006) . Moreover, researchers have demonstrated that anti-PF4/heparin antibodies bind complexes of PF4/nucleic acid (Jaax et al, 2013) and PF4/ lipopolysaccharide (LPS) (Krauel et al, 2012) . Plasma levels of nucleic acids (Ren et al, 2013) and LPS (Klein et al, 2011) increase following surgery and their ability to complex with PF4 may help explain HIT pathogenesis in patients who are not exposed to heparin. This line of evidence also suggests that HIT is a misdirected antibody response, whereby sensitizing exposure to PF4/polyanion complexes induces synthesis of anti-PF4/polyanion antibodies that cross-react with PF4/heparin following heparin infusion (Krauel et al, 2011) . Therefore, engagement of PF4 with nucleic acids, GAGs, or LPS during one's lifetime may 'prime' PF4/polyanion-specific B cells to produce HIT antibodies following heparin exposure in certain clinical circumstances.
Although typical class switching does not occur in HIT, T cells are known to play a key role in the HIT antibody response (Suvarna et al, 2005) . Patients with HIT possess T cells with TCRs that are specific for PF4/heparin (Bacsi et al, 1999) . A recent genome-wide study of HIT has shown that single nucleotide polymorphisms of the G protein-coupled receptor 65 gene (GPR65, also termed TDAG8), which is involved in regulating T cell function, are also associated with HIT (Karnes et al, 2015) . Similar to autoimmune disorders, HIT is more common in females than males and females are known to exhibit heightened T cell function and increased numbers of T H cells (Klein & Flanagan, 2016) . Pregnancy, which leads to a suppression of T cell function (Doria et al, 2006) , is also associated with a low incidence of HIT (Fausett et al, 2001) . Murine models have shown that T cells expressing both CD4 and CD40 ligand are required to generate anti-PF4/heparin IgG antibodies (Zheng et al, 2015) ; however, these antibodies were not investigated for their potential to induce Fc-receptor-specific platelet activation and cause HIT. In typical antibody responses, follicular T H cells express CD40 ligand, which engages CD40 on cognate B cells to induce class switch recombination, germinal centre formation, and memory cell generation (Elgueta et al, 2009 ). The precise role of T cells in HIT remains unclear. Mice lacking functional TCRs can still produce anti-PF4/heparin IgM antibodies, suggesting that HIT antibody formation can partially be carried out by innate-like antibody mechanisms (Krauel et al, 2016) . Marginal zone B cells, which can produce antibodies without T cell help, are also capable of anti-PF4/heparin IgG antibody production (Zheng et al, 2013) . Overall, the evidence for T cell dependence in HIT is controversial due to (i) lack of evidence that HIT antibodies produced by immunodeficient mice can activate platelets, (ii) lack of human studies that assess the relationship between T cell activation and HIT antibody formation, and (iii) lack of mechanistic evidence showing that sensitizing exposure to PF4/polyanion complexes can induce T cell-dependent B cell activation and a secondary antibody response with primary exposure to heparin.
HIT has features of a T cell-independent antibody response
Studies have also demonstrated that HIT antibody formation might not entirely depend on the activation of T cells. Despite pharmacological suppression of T cells, patients who have undergone liver transplantation surgery can still produce HIT antibodies with platelet-activating function (Bakchoul et al, 2014) . Furthermore, human immunodeficiency virus (HIV) -positive patients, who possess low numbers of T H cells, pose an increased risk of developing HIT (Thompson et al, 2007) . PF4 also inhibits T cell proliferation and secretion of IL-2, an interleukin that promotes T cell activation (Fleischer et al, 2002) . HIT is consistent with a T cellindependent pathway due to the lack of immune memory, as evinced by transient serology (Warkentin & Kelton, 2001 ) and a lack of antigen-specific memory B cells (Selleng et al, 2010) . Heparin re-exposure does not induce reliable recurrences of HIT nor does it lead to a classic secondary antibody response (Warkentin & Sheppard, 2014) . Taken together, the ability for patients with suppressed cellular immunity to develop HIT, the transient nature of HIT antibodies, and the lack of immune memory in HIT suggest that the HIT antibody response can occur independent of T cells.
Antigens that can directly activate B cells without the help of T cells are classified as T cell-independent type 1 (TI-1) or type 2 (TI-2) antigens. TI-1 antigens, such as LPS, interact with toll-like receptors (TLRs), which are a type of pattern recognition receptor, and can induce nonspecific B cell activation (Lesinski & Westerink, 2001 ). TI-2 antigens are rigid and multivalent molecules with a high molecular weight; these molecules, which include capsular polysaccharides and protein aggregates, crosslink B cell receptors (BCRs) on mature B cells to induce antigen-specific B cell activation (Vos et al, 2000) . Both T cell-independent antigens produce a less robust and lower affinity antibody response than antigens that stimulate T cell-dependent pathways (Toellner et al, 2002) . T cell-independent antibody responses are classically predominated by IgM with no secondary IgG antibody response. However, the production of IgG antibodies is possible without T cell help, as it can occur in conjunction with B cell activation by TLRs, B cell-specific cytokines (Pone, 2012; Pone et al, 2015) , and/or complement proteins (Szomolanyi-Tsuda et al, 2006) . Therefore, in the event that HIT is shown not to be a T cell-dependent secondary antibody response to PF4/polyanion exposure, rapid T cell-independent IgG production following primary PF4/heparin exposure represents a viable alternative hypothesis. T cellindependent antigens can generate a unique family of memory B cells that are less functional and have a shorter lifespan Review than typical memory B cells (Defrance et al, 2011) . T cellindependent antigens also interact preferentially with marginal zone B cells and B1 cells, which express pattern recognition receptors and BCRs of limited antigenic diversity that produce polyreactive antibodies capable of binding evolutionarily conserved antigens (Cerutti et al, 2013) . HIT antibodies are likely polyreactive, given their ability to bind PF4/heparin and other similar PF4/polyanion complexes with varying affinity (Newman & Chong, 1999) . T cellindependent pathways might therefore underlie features of the atypical antibody response in HIT.
The role of innate-like B cells in HIT
Marginal zone B cells can rapidly produce T cell-independent antibodies against blood-borne pathogens (Cerutti et al, 2013) . Human marginal zone B cells develop after 2 years of age and reside within both the spleen and circulation (Weller et al, 2004) . These cells typically secrete IgM antibodies, but, under certain conditions, can produce IgG and IgA antibodies (MacLennan et al, 2003; Kaminski & Stavnezer, 2006) . Murine HIT models have shown that marginal zone B cells are required to produce anti-PF4/heparin IgG antibodies (Zheng et al, 2013) . In addition, complement proteins bind PF4/heparin and mediate binding to complement receptor 2 (CR2) on >90% of human B cells (Khandelwal et al, 2016) . CR2, which is expressed by marginal zone B cells (Pillai et al, 2005) , can directly activate other B cells via complement-coated antigen or shuttle complexes to follicular dendritic cells, which can amplify B cell activation (Khandelwal et al, 2016) . Follicular dendritic cells, which reside within secondary lymphoid tissues, can also activate B cells via the presentation of unprocessed TI-2 antigens (El Shikh et al, 2009). Novel roles for complement activation and marginal zone B cells in HIT suggest that innate immune activation is critical to the HIT antibody response.
Ligand-specific engagement of pattern recognition receptors, including TLRs, are required to mobilize innate immune cells and synthesize proinflammatory cytokines (Warrington et al, 2011) . PF4/heparin complexes with a net positive charge can engage TLR4 to induce immune activation via IL-8 secretion (Prechel & Walenga, 2015) ; this interaction may facilitate antigen presentation to T cells and/or potentiate B cell activation during the HIT antibody response. At a certain stoichiometric ratio, PF4/heparin can behaves as a generalized immune activator in patients who produce HIT antibodies. TLRs primarily induce cellular activation via the adaptor protein, myeloid differentiation factor 88 (MYD88); however, TLR4 can signal through either a MYD88-dependent or a MYD88-independent pathway (Fitzgerald et al, 2003) . In murine HIT models, both MYD88-deficient and wild-type mice produce anti-PF4/ heparin IgG antibodies (Suvarna et al, 2008) ; thus, if activation of TLR4 contributes directly to B cell activation in HIT, it likely occurs through the MYD88-independent pathway, but this has not been investigated experimentally. TLR4 is not typically expressed on resting human B cells, but expression can be increased by specific stimuli, such as IL-4 (Vaure & Liu, 2014) , or inflammatory states (Ganley-Leal et al, 2010) . Furthermore, integration of BCR and TLR4 signals can synergize to induce T cell-independent IgG antibody production , while combined BCR-TLR engagement can suppress immune tolerance and permit autoantibody formation (Suurmond & Diamond, 2015) . In murine models, repetitive autoantigens have been shown to potentiate IgM and IgG autoantibody production by marginal zone B cells (Palm et al, 2015) . Surgical trauma may facilitate TLR expression, and, in conjunction with activation by PF4/heparin, induce marginal zone B cells to synthesize antibodies against the modified PF4 autoantigen in HIT.
In addition to marginal zone B cells, B1 cells also contribute to anti-PF4/heparin IgM antibody production (Krauel et al, 2016) . B1 cells respond to T cell-independent antigens and primarily secrete polyreactive IgM antibodies that can bind both autoantigens and foreign proteins (Baumgarth, 2011) . Human B1 cells are produced in utero and can persist in adult circulation (Montecino-Rodriguez & Dorshkind, 2012) . Anti-PF4/heparin IgM antibody production has been shown to begin prior to 6 months of age, while anti-PF4/heparin IgG antibodies are only detectable in adulthood (Krauel et al, 2016) . HIT is also exceedingly rare in children (Avila et al, 2013) , which suggests that B1 cells are probably not required for HIT IgG antibody formation, but may be involved in the innate component of the HIT antibody response (Krauel et al, 2016) . The interactivity between innate and adaptive immunity in HIT is complex and the role of innate-like B cells in mediating HIT immunobiology is not fully understood.
The structure of PF4/heparin resembles a T cellindependent antigen PF4/heparin resembles TI-2 antigens, which are multivalent, rigid, and linear molecules with molecular weights ≥100 kDa and epitopes spaced regularly apart by 5-10 nm (Vos et al, 2000) . Equimolar PF4/heparin ratios form a >670 kDa charge-neutralized complex that optimizes HIT antibody binding . Within this complex, PF4 epitopes are separated regularly by approximately 3-5 nm , but this distance may be altered by the aggregation of multiple complexes. Polyanions can stabilize PF4 tetramers and induce conformational and structural changes that permit anti-PF4/heparin antibody binding (Cai et al, 2015) . However, it is not yet known whether the structural properties of PF4/heparin allow it to crosslink BCRs and activate B cells independent of T cells. Moreover, the ability for PF4/heparin to engage TLRs suggests that this complex may mediate non-specific B cell activation by functioning as a TI-1 antigen (Prechel & Walenga, 2015) . Further studies are required to elucidate the immunogenic properties of PF4/heparin and determine how these properties are related to HIT pathogenesis. The temporary loss of immune tolerance may explain the unique immune features of HIT Tissue trauma causes cellular damage and facilitates exposure to damage-associated molecular patterns (DAMPs) and pathogen-associated molecular patterns (PAMPs), both of which can facilitate a breakdown in immune tolerance (Anders & Schaefer, 2014) . Major surgery induces a global inflammatory response that releases DAMPs and PAMPs, which can activate immune cells, complement, and coagulation pathways (Dobson, 2015) . Moreover, major surgery has been shown to be an independent predictor of HIT (Lubenow et al, 2010) . Following the inflammatory phase, severe trauma also induces immunosuppression, during which, regulatory lymphocytes dampen inflammation and promote healing (Flohe et al, 2008) ; however, an inhibition of these regulatory mechanisms during the immediate inflammatory phase may increase the likelihood of postoperative autoimmune responses. Regulatory lymphocyte function can be suppressed by the release of proinflammatory cytokines, PAMPs, and DAMPs (Smigiel et al, 2014) . In patients who develop HIT postoperatively, a suppression of immune regulation may potentiate the immune response against PF4. Bacterial translocation and cellular damage is a common consequence of major surgery (Dobson, 2015) , and is therefore unlikely to occur exclusively in surgical patients who develop HIT. However, a breakdown in immune regulation may play an important role in the large subset of surgical patients who produce anti-PF4/heparin antibodies postoperatively. Surgical patients who do not produce antibodies against PF4/heparin may possess protective factors that prevent autoreactive lymphocyte activation. HIT is a rare iatrogenic disorder that requires the convergence of clinical, genetic, and immunological factors (Fig 1) . Therefore, a transient loss of immune tolerance following surgery is likely necessary, but not sufficient for HIT pathogenesis.
Regulatory lymphocytes suppress inflammatory processes and help to maintain tolerance against autoantigens (Sakaguchi et al, 2009) . Abnormal function of regulatory T cells is a major factor in the onset of autoimmune disease (Fujio et al, 2013) . Studies have demonstrated that human regulatory T cell function is impaired by PF4 (Liu et al, 2005) . A transient rise in the perioperative levels of PF4 may temporarily suppress regulatory T cell function and potentiate autoreactive lymphocyte activation. Future studies are required to determine whether the function of regulatory lymphocytes is altered in surgical patients who develop HIT.
Few studies have directly evaluated a role for immune regulation in HIT. Human B cells activated by a polyclonal stimulus and mice lacking functional tolerance mechanisms can spontaneously produce anti-PF4/heparin antibodies (Zheng et al, 2014) . Polymicrobial sepsis also leads to the production of anti-PF4/heparin IgM antibodies without exposure to PF4/heparin (Krauel et al, 2016) . Furthermore, systemic autoimmunity, which is associated with suppressed immune regulation, can lead to the production of both heparin-dependent and heparin-independent anti-PF4 antibodies (Satoh et al, 2012) . Taken together, these findings suggest that PF4-specific autoreactive B cells are under regulatory control in healthy states, but become activated in the midst of inflammation and suppression of immune regulation. Table I . T cell-dependent and T cell-independent immunobiology in HIT.
Breakdown of immune regulation

Heparin-induced thrombocytopenia
Evidence for T cell-dependent antibody response in HIT Evidence for T cell-independent antibody response in HIT
• Expression of CD4 and CD40 ligand on T cells are required for anti-PF4/heparin IgG antibody production (Zheng et al, 2015) • Prior exposure to PF4/polyanion complexes can conceptually explain rapid IgG antibody response following initial heparin exposure (Krauel et al, 2011) • Antigen-presenting cells express MHC class II and co-stimulatory molecules after PF4/heparin phagocytosis (Joglekar et al, 2015) • HIT patients possess PF4/heparin-specific T cells in circulation (Bacsi et al, 1999) • Lack of a classical secondary antibody response and HIT recurrence with repeat heparin exposure (Warkentin & Sheppard, 2014) • PF4/heparin has intrinsic characteristics of a T cell-independent antigen (Zheng et al, 2013) • T cell suppression does not prevent the production of HIT antibodies (Bakchoul et al, 2014) • Lack of PF4/heparin-specific memory B cells with production of anti-PF4/heparin IgG antibodies (Selleng et al, 2010) • Marginal zone B cells are required for anti-PF4/heparin IgG antibody production (Zheng et al, 2013) HIT, heparin-induced thrombocytopenia; IgG, immunoglobulin G; MHC, major histocompatibility complex; PF4, platelet factor 4.
HIT is characterized by both T cell-dependent and T cell-independent antibody responses
The unique antibody response in HIT is characterized by four main features: (i) anti-PF4/heparin IgG antibodies are generated without a precedent IgM response after primary heparin exposure ; (ii) anti-PF4/ heparin IgG antibodies can be detected as early as 3 days after heparin exposure (Greinacher et al, 2009) ; (iii) anti-PF4/heparin IgG antibodies are transient and disappear within months (Warkentin & Kelton, 2001; Potschke et al, 2012) ; and (iv) re-exposure to heparin after HIT is unlikely to induce recurrences of HIT (Warkentin & Sheppard, 2014 ).
As we have discussed throughout this article, neither a T cell-dependent nor a T cell-independent model alone can explain all of these disease features (Table I) . Therefore, we propose a combined model of immunobiology, which suggests that both T cell-dependent and T cell-independent mechanisms are necessary for HIT pathogenesis (Fig 2) . As described previously, prior exposure to PF4/polyanion complexes may sensitize lymphocytes in a T cell-dependent fashion to rapidly produce cross-reactive antibodies that can bind PF4/heparin following heparin exposure (Krauel et al, 2011 ). In our model of HIT immunobiology, we further suggest that co-stimulatory signals derived from surgical trauma, in conjunction with PF4/heparin, may produce anti-PF4/heparin antibodies in a T cell-independent manner. Complement proteins can be active in both T celldependent and T cell-independent antibody responses (Szomolanyi-Tsuda et al, 2006); therefore, the newly discovered role for complement in HIT does not preclude either pathway and suggests that future research is needed to elucidate possible roles for complement-dependent immune mechanisms in HIT pathogenesis. Major cardiac surgery transiently suppresses cellular immunity (Franke et al, 2006) ; thus, rapid T cell-independent antibody production immediately after surgery may help to maintain host defence until T cell function is regained. However, in the subset of surgical patients who develop HIT, this rapid T cell-independent antibody response may be harmful when directed against PF4. As we described in the previous section, a transient loss of immune regulation following surgery may precede the activation of PF4-specific autoreactive lymphocytes in patients who produce HIT antibodies.
In contrast to our model, a single immunobiological pathway may also explain the production of polyclonal HIT antibodies; however, it is difficult to characterize the atypical features of HIT using either a T cell-dependent or T cellindependent mechanism. A recent study has shown that HIT antibody binding is largely dependent on the structural characteristics of PF4/heparin (Cai et al, 2015) , but these authors did not investigate the immunobiology underlying HIT antibody production. Our model suggests that distinct, but interconnected, immunobiological pathways may be able to explain the existence of anti-PF4/heparin antibodies with different binding affinities and functional characteristics.
Our model is the first attempt at consolidating the controversial body of literature into HIT immunobiology. Experimental validation using human and animal models is required to determine whether PF4/heparin behaves as a T cell-independent antigen and whether this mechanism contributes to HIT pathogenesis. In addition to the HIT serological studies, functional investigations of immune cells derived from HIT patients are required to determine the role for different immune cell subsets, including regulatory lymphocytes, in active episodes of HIT.
Conclusion
HIT represents a unique antibody-mediated drug reaction with features of both T cell-dependent and T cell-independent pathways. A temporary loss of immune regulation may underlie PF4-specific lymphocyte activation and help to explain the postoperative production of HIT antibodies. Further insight into the immunogenesis of HIT will improve our understanding of normal and pathological immunity and help to advance therapeutics in HIT. 
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